Kim R Tsuchimoto
CIK 1333516 · Chief Financial Officer · last filed 2025-12-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.19M
Companies
3
Total Filings
41
Lifetime Open-Market Net
-$441.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MNPR | Chief Financial Officer | 20,390 | $107.42 | $2.19M | -$353.6K | 23 | 2025-12-08 |
| Raptor Pharmaceutical Corp (RPTP) Delisted | Chief Financial Officer | 4,092 | — | — | -$87.4K | 12 | 2012-09-27 |
| Raptor Pharmaceutical Corp (RPTPD) Delisted | Chief Financial Officer | 582 | — | — | $0 | 1 | 2009-10-01 |
Recent Filings · Page 3 of 5
41 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-01-28 | MNPR | Grant (A) | — | $0 | EDGAR |
| 2021-01-05 | MNPR | Mixed | +727 | -$3.1K | EDGAR |
| 2020-02-20 | MNPR | Grant (A) | — | $0 | EDGAR |
| 2019-12-20 | MNPR | Buy (P) | +325 | $2.6K | EDGAR |
| 2018-09-27 | — | Grant (A) | — | $0 | |
| 2018-09-27 | — | Grant (A) | — | $0 | |
| 2012-09-27 | Raptor Pharmaceutical Corp (RPTP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-08-31 | Raptor Pharmaceutical Corp (RPTP) Delisted | Mixed | — | -$8.5K | EDGAR |
| 2012-08-29 | Raptor Pharmaceutical Corp (RPTP) Delisted | Mixed | — | -$119 | EDGAR |
| 2012-06-18 | Raptor Pharmaceutical Corp (RPTP) Delisted | Mixed | — | -$11.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.